⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144046 | 0.68 | — | — | |
| SCHEMBL9301981 | 0.67 | — | — | |
| SCHEMBL13931347 | 0.66 | — | — | |
| SCHEMBL18400695 | 0.62 | — | — | |
| SCHEMBL4332242 | 0.60 | — | — | |
| SCHEMBL4332245 | 0.60 | — | — | |
| SCHEMBL24736622 | 0.60 | DDAH1 (0.34) | — | |
| SCHEMBL19800945 | 0.60 | HSD17B10 (0.30) | — | |
| SCHEMBL22756387 | 0.59 | — | — | |
| SCHEMBL3699301 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11198693-B2 | Functionalized heterocycles as antiviral agents | ENANTA PHARMACEUTICALS, INC. (US) | 2021-12-14 | — | — | US | disclosed |
| US-20200165249-A1 | FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS | ENANTA PHARMACEUTICALS, INC. | 2020-05-28 | — | — | US | disclosed |